SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Staff Back Higher Dose of Boehringer Ingelheim Corporation Clot Drug

September 16, 2010 | 
1 min read
LONDON, Sept 16 (Reuters) - Boehringer Ingelheim's new anticoagulant pill Pradaxa should be approved in the higher of two suggested doses for the prevention of strokes in people with irregular heartbeats, U.S. drug reviewers said on Thursday.
Regulatory Europe
Boehringer Ingelheim Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
FDA
FDA’s Hoeg Reportedly Trying To Hire Friend, Fellow Antidepressant Skeptic
March 5, 2026
 · 
2 min read
 · 
Tristan Manalac
Business decision concept with a businessman standing on a huge question mark. Symbol of the future, opportunities, planning, vision. Vector illustration
Regulatory
PepGen’s Mid-Stage Myotonic Dystrophy Study Hit With ‘Surprise’ Pause
March 5, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of a yellow envelope on a blue background with a read warning symbol
Supply chain
FDA Sends 30 Warning Letters To Continue Clampdown on Compounded GLP-1s
March 4, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Podcast
UniQure’s Delay, REGENXBIO’s Rejection Explained, Sarepta’s Ingram Steps Down, More
March 4, 2026
 · 
1 min read
 · 
Heather McKenzie